Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15114097 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Simultaneous Pancreas-kidney Transplantation With Campath Protocol
Condition: Pancreas-Kidney Transplantation
Interventions: Drug: Alemtuzumab;   Drug: Rabbit Anti-Human Thymocyte Globulin

Study has passed its completion date and status has not been verified in more than two years.